TPG Growth Invests $30M in Solara Active Pharma
February 4, 2019
TPG Growth will invest $30 million in Solara Active Pharma to support the Indian API manufacturer's growth and capacity expansion into regulated markets. The minority growth equity investment is intended to help Solara scale manufacturing and R&D capabilities and strengthen its position with global generic customers in the US and Europe.
- Buyers
- TPG Growth
- Targets
- Solara Active Pharma
- Industry
- Pharmaceuticals
- Location
- Karnataka, India
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
TPG Growth Invests $150 Million in Tessolve
September 4, 2025
Engineering Services
TPG Growth has invested $150 million in Tessolve, a global semiconductor and embedded engineering services provider, in a growth equity transaction. The capital will be used to expand R&D and test lab capacity, strengthen global delivery centers, and support strategic acquisitions as Tessolve scales its semiconductor engineering capabilities.
-
TPG Rise Climate Acquires Majority Stake in Aurora Energy Research
June 4, 2025
Data & Analytics
TPG Rise Climate (TPG) has agreed to acquire a majority stake in Aurora Energy Research from CGE Partners, with CGE reinvesting alongside 22C Capital and Aurora management. Aurora — an Oxford-based energy market analytics and software platform serving utilities, governments and investors — will scale its data, analytics and software capabilities globally with TPG’s climate investing resources and 22C’s operational support.
-
TPG Completes Majority Investment in iNova Pharmaceuticals
October 31, 2022
Pharmaceuticals
TPG (through its Asia platform) completed a majority investment in iNova Pharmaceuticals, a multinational consumer health and pharmaceutical company, with existing investor Pacific Equity Partners re-investing as a minority co-investor. The deal will support iNova's regional expansion and growth strategy across Southeast and North Asia, and fund channel expansion, product-in-fill and technology investments.
-
TPG Makes >$100M Growth Investment in EIS
June 29, 2021
Cloud & SaaS
TPG, via its TPG Tech Adjacencies fund, made a growth investment of more than $100 million in EIS, a San Francisco–based cloud-native insurance software platform. The capital will be used to accelerate product development across risk, health and wealth lines and to support geographic expansion.
-
Solara Medical Supplies Acquires Active Healthcare's Diabetes Supplies Business
May 15, 2020
Healthcare Services
Solara Medical Supplies, a Linden Capital Partners–backed direct-to-patient diabetes distributor, acquired the diabetes supplies business of Active Healthcare, Inc., a North Carolina-based provider of continuous glucose monitors, insulin pumps and related supplies. The add-on expands Solara’s geographic presence and patient-service capabilities in North Carolina and builds on Solara’s prior platform investments under Linden Capital Partners.
-
TPG Capital and Vida Ventures Invest $225M in Asklepios BioPharmaceutical (AskBio)
April 11, 2019
Biotechnology
Asklepios BioPharmaceutical (AskBio) raised $235 million in new capital, with TPG Capital and Vida Ventures investing $225 million for a minority stake while AskBio’s founders and board co-invested $10 million. The funding will be used to accelerate clinical development and expand manufacturing capabilities, particularly for AskBio’s AAV gene therapy platform and pipeline.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.